Watson/P&G Macrobid “Authorized” Generic Challenged By Mylan
Executive Summary
Mylan argues an "authorized" generic agreement between Watson and Procter & Gamble for a version of Macrobid inhibits competition
You may also be interested in...
“Authorized” Generic Opponents Turn To State Laws After Federal Court Loss
Generic companies are pursuing alternative litigation routes in their efforts to block "authorized" generics following a Washington, D.C. appeals court decision upholding FDA's current policy on the products
“Authorized” Generic Opponents Turn To State Laws After Federal Court Loss
Generic companies are pursuing alternative litigation routes in their efforts to block "authorized" generics following a Washington, D.C. appeals court decision upholding FDA's current policy on the products
Mylan Challenge To “Authorized” Generics May Shift To Antitrust Arguments
Mylan could turn to antitrust laws as an avenue for renewing a court challenge against "authorized" generics after dropping its lawsuit against FDA